84. サルコイドーシス [臨床試験数:143,薬物数:221(DrugBank:79),標的遺伝子数:82,標的パスウェイ数:165

Searched query = "Sarcoidosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
5 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00731757May 20096/8/2008Efficacy Study of Humira in the Treatment of Cutaneous SarcoidosisA Phase II, Multi-Center, Open Label Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous SarcoidosisSarcoidosis;Cutaneous SarcoidosisDrug: HumiraWright State UniversityStanford UniversityWithdrawn18 YearsN/ABoth20Phase 2United States
2NCT00690911August 20072/6/2008Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous SarcoidosisA Phase II, Multi-Center, Open Label Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis (HUM 04-36)SarcoidosisDrug: adalimumabWake Forest UniversityNULLWithdrawn18 YearsN/AAll0Phase 2United States
3NCT00274352September 20066/1/2006A Study of Adalimumab to Treat Sarcoidosis of the SkinA Double-Blind, Randomized, Placebo-Controlled Study of Adalimumab in the Treatment of Cutaneous SarcoidosisSarcoidosisDrug: adalimumabPariser, Robert J., M.D.Abbott;Virginia Clinical Research, Inc.Completed18 Years89 YearsBoth16Phase 2United States
4EUCTR2006-001816-56-DK11/05/200628/04/2006Can PET scan be used to assess disease activity in patients with sarcoidosis during treatment with adalimumab (Humira)? - KOMPLETCan PET scan be used to assess disease activity in patients with sarcoidosis during treatment with adalimumab (Humira)? - KOMPLET sarcoidosisTrade Name: Humira
Product Name: Humira
RigshospitaletNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
10Phase 2Denmark
5NCT00311246April 20063/4/2006Trial of Adalimumab in Progressive SarcoidosisA Prospective Open-Label Trial of Adalimumab in Progressive SarcoidosisSarcoidosisDrug: AdalimumabUniversity of ChicagoAbbottTerminated18 Years85 YearsAll11Phase 2United States